INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Neos Therapeutics, Inc. and Encourages Investors with
Losses to Contact the Firm
Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Neos Therapeutics, Inc. (“Neos” or the
“Company”) (Nasdaq: NEOS) concerning possible violations of federal securities laws.
If you purchased shares of Neos and want more information, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101
Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.
The investigation focuses on the August 11, 2016 announcement of Neos’ financial results for the second quarter of 2016,
reporting that it missed its earnings expectations by $0.49 per share. When this information was disclosed, shares of Neos fell in
value.
If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost
two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.
This press release may constitute Attorney Advertising in some jurisdictions.
Khang & Khang LLP
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160919006105/en/